Viral ‘Molecule’ Pill Sparks Health Crisis Among Russian Teens

Moscow– A dangerously addictive weight-loss pill dubbed “Molecule” is surging in popularity among Russian teenagers, fueled by TikTok influencers and black-market sales, leading to a wave of hospitalizations and urgent calls for a nationwide ban.

Promoted as a “miracle” slimming aid, the unregulated capsules—sold for as little as 200 rubles ($2) per pack on Telegram channels—promise rapid fat loss without diet or exercise. Recent lab tests by Russian health authorities have confirmed the pills contain sibutramine, a banned appetite suppressant pulled from global markets in 2010 over links to heart attacks and strokes, alongside unlisted stimulants like caffeine and ephedrine.  Users as young as 14 report severe side effects, including palpitations, nausea, insomnia, and fainting, with emergency room visits among adolescents spiking 30% in major cities like Moscow and St. Petersburg over the past month.
Twenty-two-year-old Maria Ivanovna, a former user from Yekaterinburg, shared her ordeal with the BBC: “I lost 10 kilos in two weeks, but then my heart started racing so fast I blacked out. It’s not worth it—doctors say it could have killed me.” Experts warn the drug’s low cost and viral hype, amplified by influencers flaunting “before-and-after” transformations, exploit body image insecurities amid Russia’s rising youth obesity rates.
Russia’s Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) has launched raids on illicit sellers, seizing thousands of packets, but the underground trade persists. Pediatrician Dr. Elena Petrova told state media: “This is a ticking time bomb for our youth—addiction risks and organ damage could scar a generation.”

As awareness grows, social media campaigns urge teens to #DitchMolecule, but officials say stricter platform regulations are needed to curb the spread. With winter holidays approaching, health advocates fear a fresh surge in misuse.

Related Posts

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

New Delhi: Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP in…

STF busts fake meds racket spread across 6 states

Dehradun: Uttarakhand special task force (STF) on Friday busted an online fake medicine racket operating through a Facebook page that allegedly sold counterfeit drugs, including cancer medicines, at discounts of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states

All the Way from Teeth to Tee: Hole in One

All the Way from Teeth to Tee: Hole in One

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug